Revolution Medicines
RVMD
161.20
+1.77
+1.11%
Revolution Medicines
US · RVMD
#499 by market cap
Listed 2020
161.20
+1.77
+1.11%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
C+
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 23 analysts
Buy
Avg price target 268.26 +66.4%
Price target rangecurrent 161.20
Low179.00
Avg268.26
High350.00
Buy 96%
Hold 4%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-20 | Bernstein | -- | Hold | 179.00 |
| 2026-11-20 | Stifel | -- | Buy | 230.00 |
| 2026-11-17 | H.C. Wainwright | -- | Buy | 350.00 |
| 2026-11-13 | Morgan Stanley | -- | Buy | 247.00 |
| 2026-11-12 | BofA Securities | -- | Buy | 274.00 |
| 2026-11-09 | Stifel | -- | Buy | 230.00 |
| 2026-11-09 | J.P. Morgan | -- | Buy | 289.00 |
| 2026-11-06 | Morgan Stanley | -- | Buy | 272.00 |
| 2026-11-06 | H.C. Wainwright | -- | Buy | 350.00 |
| 2026-11-05 | TD Cowen | -- | Buy | 270.00 |
| 2026-11-05 | Piper Sandler | -- | Buy | 222.00 |
| 2026-11-05 | BofA Securities | -- | Buy | 274.00 |
| 2026-11-05 | Wedbush | -- | Buy | 225.00 |
| 2026-11-05 | Morgan Stanley | -- | Buy | 272.00 |
| 2026-11-05 | Evercore | -- | Buy | 340.00 |
| 2026-11-05 | Stifel | -- | Buy | 230.00 |
| 2026-11-05 | Oppenheimer | -- | Buy | 260.00 |
| 2026-11-05 | RBC Capital | -- | Buy | 321.00 |
| 2026-11-04 | Guggenheim | -- | Buy | 298.00 |
| 2026-11-04 | J.P. Morgan | -- | Buy | -- |
| 2026-10-27 | RBC Capital | -- | Buy | 260.00 |
| 2026-10-26 | BofA Securities | -- | Buy | 264.00 |
| 2026-10-22 | UBS | -- | Buy | 265.00 |
| 2026-10-22 | Morgan Stanley | -- | Buy | 255.00 |
| 2026-10-21 | TD Cowen | -- | Buy | 250.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-04 | After close | ±9.93% | -11.04% (beat) |
| 2026/Q2 | 2026-08-05 | After close | ±8.35% | +0.26% (in line) |
| 2026/Q1 | 2026-05-06 | After close | ±5.47% | -5.67% (beat) |
| 2025/Q4 | 2026-02-25 | After close | ±11.64% | -1.06% (in line) |
| 2025/Q3 | 2025-11-05 | After close | ±8.59% | +3.44% (in line) |
| 2025/Q2 | 2025-08-06 | After close | ±11.09% | -4.69% (in line) |
| 2025/Q1 | 2025-05-07 | After close | ±12.35% | +11.29% (in line) |
| 2024/Q4 | 2025-02-26 | After close | ±8.64% | -3.51% (in line) |
| 2024/Q3 | 2024-11-06 | After close | ±11.89% | -0.54% (in line) |
| 2024/Q2 | 2024-08-07 | After close | ±13.30% | -0.69% (in line) |
| 2024/Q1 | 2024-05-08 | After close | ±17.23% | -2.24% (in line) |
| 2023/Q4 | 2024-02-26 | After close | ±12.91% | +0.79% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:24 · For reference only, not investment advice and not tailored to your situation.
Revolution Medicines discussion 0 comments